CI

At a glance

ClinicalIndex Comparison Record
N/ATerminated· 88 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01851421
NCT01851421N/ATerminated
Terminated

Fat Metabolism and Function Altering Polymorphisms in MC3R

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·observational·Posted May 10, 2013·Updated Jun 30, 2021

In Brief

An observational study for Obesity and Healthy Volunteers. Terminated early, enrolled 88 participants across 1 site.

Signals

Trial was terminated early

Detailed Summary

Background: \- Melanocortin receptors are proteins in the body that help send messages between body systems. One such receptor, the melanocortin 3 receptor (MC3R), is important for regulating body weight. Differences in MC3R can affect fat metabolism - or how the body handles fat. Some people who have changes in the MC3R genetic code are heavier than those who do not have these changes. These changes are found more often in African Americans. Researchers want to study the MC3R in African American adults to see how these changes may affect fat metabolism. They will look at overweight adults with either the most common genetic code for the MC3R or a rare variant. Objectives: \- To study the role of the MC3R in body weight and fat metabolism. Eligibility: * Healthy African American volunteers between 18 and 55 years of age. * Volunteers must be overweight (body mass index at least 30 kg/m2) but weigh less than 450 lbs. Design: * The study consists of an outpatient screening visit and a 7-day inpatient visit with dietary studies. * Participants will be screened with a physical exam and medical history. Blood samples will be collected. (Participants will need to fast for 10 hours before giving blood samples.) A body scan will be given to determine fat, bone, and muscle content. Participants will complete a 3-day dietary assessment to record their food and drink consumption. They will also have an exercise test to look at heart and lung function. * Participants will have a 7-day inpatient stay. They will have a regular diet for the first 3 days of the study. For the final 4 days, they will have a diet with a higher fat content. * During the inpatient visit, participants will have the following study procedures: * Body measurements * Daily exercise routine * Imaging studies of the body * Measurement of a whole day s energy expenditure (spending one day in metabolic chamber-day 5) * Frequent blood samples * Urine collection for 24 hours (days 3 and 7) * Fat biopsy (collection of a small sample of fat tissue from under the skin on the abdomen) * Insulin and metabolism tests while eating the two different diets (day 4 and day 7). * After the final insulin and metabolism test, participants will be discharged from the study.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ATerminatedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 10, 2013
Enrollment StartSep 23, 2013
Primary CompletionOct 13, 2020
Study CompletionJun 28, 2021
TodayJul 1, 2026
Enrollment to primary: 7.1 yearsPosted 13.1 years ago